SUPN - SUPERNUS PHARMACEUTICALS, INC.

Dashboard

Manage Tickers Link Financial Account

SUPNSUPERNUS PHARMACEUTICALS, INC.

Nasdaq supernus.com

$ 25.99 $ 0.02 (0.08 %)

Friday, 05-Jul-2024 15:59:22 EDT

CLICK TO SEE RELEVANT LITIGATION UPDATES

Y-mAbs Therapeutics, Inc. | YMAB | Take Action!

QQQ $ 495.80 $ 5.12 (1.04 %)

DIA $ 393.71 $ 0.87 (0.22 %)

SPY $ 554.29 $ 3.18 (0.58 %)

TLT $ 92.56 $ 0.76 (0.83 %)

GLD $ 220.89 $ 2.94 (1.35 %)

Previous Close

$ 26.03

Open

$ 25.87

Bid

$ 25.98 x 421

Ask

$ 0.00 x 0

Day's Range

$ 25.71 - $ 26.06

52 Week Range

$ 21.99 - $ 35.44

Volume

223,656

Average Volume

na

Market Cap

1.45B

Beta (5Y Monthly)

$ 0.81

PE Ratio (TTM)

nm

EPS (TTM)

TBD

Earnings Date

na

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

na

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
1	05-08-2024	03-31-2024	10-Q
2	02-27-2024	12-31-2023	10-K
3	11-08-2023	09-30-2023	10-Q
4	08-08-2023	06-30-2023	10-Q
5	05-09-2023	03-31-2023	10-Q
6	03-09-2023	12-31-2022	10-K
7	11-09-2022	09-30-2022	10-Q
8	08-08-2022	06-30-2022	10-Q
9	05-12-2022	03-31-2022	10-Q
10	04-13-2022	12-31-2021	10-K
11	11-05-2021	09-30-2021	10-Q
12	08-06-2021	06-30-2021	10-Q
13	05-07-2021	03-31-2021	10-Q
14	03-08-2021	12-31-2020	10-K
15	11-06-2020	09-30-2020	10-Q
16	08-17-2020	06-30-2020	10-Q
17	05-15-2020	03-31-2020	10-Q
18	02-28-2020	12-31-2019	10-K
19	11-08-2019	09-30-2019	10-Q
20	08-09-2019	06-30-2019	10-Q
21	05-10-2019	03-31-2019	10-Q
22	03-01-2019	12-31-2018	10-K
23	11-09-2018	09-30-2018	10-Q
24	08-09-2018	06-30-2018	10-Q
25	05-10-2018	03-31-2018	10-Q
26	03-01-2018	12-31-2017	10-K
27	11-09-2017	09-30-2017	10-Q
28	08-03-2017	06-30-2017	10-Q
29	05-09-2017	03-31-2017	10-Q
30	03-16-2017	12-31-2016	10-K
31	01-20-2017	09-30-2016	10-Q
32	08-05-2016	06-30-2016	10-Q
33	05-10-2016	03-31-2016	10-Q
34	03-09-2016	12-31-2015	10-K
35	11-09-2015	09-30-2015	10-Q
36	08-07-2015	06-30-2015	10-Q
37	05-06-2015	03-31-2015	10-Q
38	03-12-2015	12-31-2014	10-K
39	11-12-2014	09-30-2014	10-Q
40	08-12-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Supernus Pharmaceuticals Announces Interim...
05/23/2024 20:09:21

Supernus Pharmaceuticals Reiterates FY24 R...
05/08/2024 21:25:29

Supernus Pharmaceuticals Q1 Sales $143.600...
05/08/2024 21:21:47

Supernus Pharmaceuticals (NASDAQ:SUPN) reported quarterly sales of $143.600 million which missed the analyst consensus estimate...

M8 Pharmaceuticals Signs An Exclusive Lice...
05/07/2024 14:03:00

M8 Pharmaceuticals, an Acino company ('M8') announces that the company has signed an exclusive licensing agreement with...

supernus-pharmaceuticals-faces-second-fda-rejection-for-investigational-device-for-parkinsons-disease

Supernus Pharmaceuticals Faces Second FDA ...
04/08/2024 14:11:37

Supernus Pharmaceuticals receives FDA Complete Response Letter for SPN-830, an investigational apomorphine infusion device for ...

12-health-care-stocks-moving-in-mondays-pre-market-session

12 Health Care Stocks Moving In Monday's P...
04/08/2024 12:09:45

Supernus Provides Regulatory Update For SP...
04/08/2024 12:06:03

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a biopharmaceutical company focused on developing and commercializing products fo...

Piper Sandler Maintains Overweight on Supe...
02/28/2024 15:40:29

Piper Sandler analyst David Amsellem maintains Supernus Pharmaceuticals (NASDAQ:SUPN) with a Overweight and lowers the price...

Supernus Sees FY24 Total Revenue $580M-$62...
02/27/2024 22:15:26

recap-supernus-pharmaceuticals-q4-earnings

Recap: Supernus Pharmaceuticals Q4 Earnings
02/27/2024 21:30:12

Supernus Pharmaceuticals Q4 2023 Adj EPS $...
02/27/2024 21:30:06

Supernus Pharmaceuticals (NASDAQ:SUPN) reported quarterly earnings of $0.39 per share which missed the analyst consensus estima...

earnings-scheduled-for-february-27-2024

Earnings Scheduled For February 27, 2024
02/27/2024 10:01:31

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on rev...

Supernus Pharmaceuticals Wins Infringement...
02/05/2024 13:36:59

United States District Court for the District of New Jersey ruled that Torrent Pharmaceuticals Ltd. and its subsidiary, Torrent...

Supernus Pharmaceuticals Has Granted Right...
12/19/2023 12:40:43

botox-and-similar-injections-have-associated-risks-consumer-group-pushes-for-stronger-warnings

Botox And Similar Injections Have Associat...
12/12/2023 19:04:27

Consumer advocacy group Public Citizen has filed a petition with the FDA, urging the agency to demand stronger warnings regardi...

Piper Sandler Maintains Overweight on Supe...
11/09/2023 19:56:59

Piper Sandler analyst David Amsellem maintains Supernus Pharmaceuticals (NASDAQ:SUPN) with a Overweight and raises the price...

Supernus Pharmaceuticals Narrows FY23 Reve...
11/08/2023 21:56:16

supernus-pharmaceuticals-q3-earnings-insights

Supernus Pharmaceuticals: Q3 Earnings Insi...
11/08/2023 21:30:15

Supernus Pharmaceuticals Q3 2023 EPS $(0.2...
11/08/2023 21:26:04

earnings-scheduled-for-november-8-2023

Earnings Scheduled For November 8, 2023
11/08/2023 09:21:00

Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter.

CLASS ACTION DEADLINES - JOIN NOW!

07/09/2024 Li Auto Inc. (LI)

07/12/2024 Inari Medical, Inc. (NARI)

07/12/2024 Sprout Social, Inc. (SPT)

07/15/2024 UnitedHealth Group Inc. (UNH)

07/16/2024 Teladoc Health, Inc. (TDOC)

07/16/2024 Vestis Corporation (VSTS)

07/22/2024 Cambium Networks Corporation (CMBM)

07/22/2024 Biogen Inc. (BIIB)

07/23/2024 Fastly, Inc. (FSLY)

07/29/2024 Enphase Energy, Inc. (ENPH)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)